Clinical Trial Update: SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery [NA]

View source ↗

Summary

Clinical trial update for SERI Surgical Scaffold in revision breast augmentation surgery; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Augmentation Revision Surgery

Drugs mentioned

• SERI Surgical Scaffold

Snippet

Sponsor: Sofregen Medical, Inc. | Conditions: Subjects Requiring Revision Breast Augmentation Surgery | NA | Status: COMPLETED | Results posted: 2021-12-28